Nutracéuticos (monacolina K, berberina y coenzima Q10) en pacientes con hipercolesterolemia moderada y un riesgo cardiovascular bajo-moderado. Potenciales beneficios de los tratamientos combinados(Pag.-e 101836)

  1. F.J. Fernández-Fernández 1
  2. R. Sardina-Ferreiro 1
  3. E. Ameneiros-Lago 1
  1. 1 Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, España
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2023

Número: 2

Páxinas: 7-7

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2022.101836 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Referencias bibliográficas

  • F. Martinez-Martin, E. Corbella, I. Sarasa, F. Trias, D. Petitbò, M. Licerán, et al. Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk Semergen (2022), 10.1016/j.semerg.04.005 View article Google Scholar
  • L. Righetti, C. Dall’Asta, R. Bruni Risk Assessment of RYR Food Supplements: Perception vs Reality Front Nutr, 8 (2021), p. 792529, 10.3389/fnut.2021.792529 View article View in ScopusGoogle Scholar
  • Y. Wang, X. Yi, K. Ghanam, S. Zhang, T. Zhao, X. Zhu Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption Metabolism, 63 (2014), pp. 1167-1177, 10.1016/j.metabol.2014.05.013 View PDFView articleView in ScopusGoogle Scholar
  • A.A. Momtazi, M. Banach, M. Pirro, N. Katsiki, A. Sahebkar Regulation of PCSK9 by nutraceuticals Pharmacol Res, 120 (2017), pp. 157-169, 10.1016/j.phrs.2017.03.023 View PDFView articleView in ScopusGoogle Scholar
  • H.I. Kutbi, H.Z. Asfour, A.K. Kammoun, A. Sirwi, S. Cavalu, H.A. Gad Optimization of hyaluronate-based liposomes to augment the oral delivery and the bioavailability of berberine Materials (Basel), 14 (2021), p. 5759, 10.3390/ma14195759 View PDF View in ScopusGoogle Scholar
  • A.M. Di Bisceglie, G.F. Watts, P. Lavin, M. Yu, R. Bai, L. Liu Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate BUDCA) in patients with hiperlipidemia Lipids Health Di, 19 (2020), p. 239 View PDF This article is free to access. View in ScopusGoogle Scholar
  • S. Larsen, N. Stride, M. Hey-Mogensen, C.N. Hansen, L.E. Bang, H. Bundgaard, et al. Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance J Am Coll Cardiol, 61 (2013), pp. 44-53, 10.1016/j.jacc.2012.09.036 View PDFView articleView in ScopusGoogle Scholar
  • A. Mazza, M. Nicoletti, S. Lenti, G. Torin, G. Rigatelli, M. Pellizzato, et al. Effectiveness and safety of novel nutraceutical formulation added to ezetimibe in statin-intolerant hypercholesterolemic subjects with moderate-to-high cardiovascular risk J Med Food, 24 (2021), pp. 59-66, 10.1089/jmf.2020.0019 View article View in ScopusGoogle Scholar
Fonte de datos: Dialnet